Neuphoria Therapeutics Stock (NASDAQ:NEUP)
Previous Close
$6.24
52W Range
$2.16 - $21.40
50D Avg
$12.01
200D Avg
$7.40
Market Cap
$8.52M
Avg Vol (3M)
$1.48M
Beta
0.59
Div Yield
-
NEUP Company Profile
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.